DOD Slow To Target Rising Rx Costs, Fraud Risks: Watchdog
The U.S. Department of Defense's health care arm had been too slow to respond to risks of fraud posed by drugs with rapidly rising costs, only recently updating its rules to...To view the full article, register now.
Already a subscriber? Click here to view full article